ARCHIVES

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

This article is from The Cancer Letter archive.

Vol. 33 No. 45 | December 7, 2007

Download PDF Visit The Full Archive

Related Articles

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991

Consensus Conference On Receptors Planned

June 22, 1979

ASCO Urges Steps to Eliminate Cancer Care Disparities

May 22, 2009

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Antman, Clanton begin work at NCI.

December 5, 2003

In Brief: Potter New AACI President, Sartorlli President Elect; NCI Staffers Get NIH Director’s Award

July 18, 1986